Perspectum's liver-scanning software scores FDA clearance for planning cancer surgeries
Perspectum has secured a 510(k) clearance from the FDA for its Hepatica software, which uses MRI scans of the liver to help guide cancer treatment and the removal of tumors as well as to identify patients with higher risks of poor outcomes following surgery.
Surgical success largely relies on the volume and health of the remaining liver tissue, which can be affected by underlying and chronic conditions such as fatty and alcoholic liver disease or viral hepatitis.
Perspectum’s Hepatica tool assesses the health of the liver before the procedure, employing quantitative, multiparametric MRI scans and artificial intelligence programs to separate the liver into sections. The system calculates the organ’s regional volumes while quantifying biomarkers of scar tissue, inflammation and fat.